What type of vaccine immunity controls breakthrough COVID?
Vaccine Insights 2023; 2(8), 317–321
10.18609/vac.2023.044
Published: 23 August
Viewpoint
Stephen J Kent, Miles P Davenport
“There is interest in the possibility of developing mucosally targeted vaccines in the hope these may increase mucosal antibody levels, improve protection and reduce shedding of virus...”
